These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 8066665)

  • 1. Effect of iron supplementation on the incidence of erythrocytosis following renal transplantation.
    Renoult E; Lataste A; Kessler M
    Transplant Proc; 1994 Aug; 26(4):2043-4. PubMed ID: 8066665
    [No Abstract]   [Full Text] [Related]  

  • 2. Evolution of serum ferritin levels in renal transplant recipients with severe iron overload.
    Park SB; Kim HC; Lee SH; Cho WH; Park CH
    Transplant Proc; 1994 Aug; 26(4):2054-5. PubMed ID: 8066668
    [No Abstract]   [Full Text] [Related]  

  • 3. Factors predisposing to post-renal transplant erythrocytosis. A prospective matched-pair control study.
    Kessler M; Hestin D; Mayeux D; Mertes PM; Renoult E
    Clin Nephrol; 1996 Feb; 45(2):83-9. PubMed ID: 8846535
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Response of hemoglobin, serum ferritin, and serum transferrin receptor during iron supplementation in pregnancy: a prospective study.
    Madhavan Nair K; Bhaskaram P; Balakrishna N; Ravinder P; Sesikeran B
    Nutrition; 2004 Oct; 20(10):896-9. PubMed ID: 15474878
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Risk factors of erythrocytosis post renal transplantation.
    Razeghi E; Kaboli A; Pezeshki ML; Meysamie AP; Khatami MR; Khashayar P
    Saudi J Kidney Dis Transpl; 2008 Jul; 19(4):559-63. PubMed ID: 18580013
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Iron stores in a healthy adult population in Chile].
    Grebe G; Lira P; Legues ME; Muñoz B; Foradori A
    Rev Med Chil; 1984 Sep; 112(9):884-92. PubMed ID: 6533728
    [No Abstract]   [Full Text] [Related]  

  • 7. Iron deficiency in the acute-phase reaction after open aortic surgery.
    Solis JV; Portero JL; Diaz J; Garcia R; Ligero JM; Vazquez E; Lodeiro C; Ballesteros L
    Vasc Endovascular Surg; 2006; 40(5):392-8. PubMed ID: 17038573
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Erythrocytosis after renal transplantation: review of 101 cases.
    Einollahi B; Lessan-Pezeshki M; Nafar M; Pour-Reza-Gholi F; Firouzan A; Farhangi F; Pourfarziani V
    Transplant Proc; 2005 Sep; 37(7):3101-2. PubMed ID: 16213319
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association between transferrin receptor-ferritin index and conventional measures of iron responsiveness in hemodialysis patients.
    Chen YC; Hung SC; Tarng DC
    Am J Kidney Dis; 2006 Jun; 47(6):1036-44. PubMed ID: 16731299
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Successful treatment of post-renal transplant erythrocytosis with enalapril.
    Rostaing L; Boisseau M; Durand D; Huyn A; Lloveras JJ; Suc JM
    Transplant Proc; 1993 Jun; 25(3):2325-6. PubMed ID: 8516915
    [No Abstract]   [Full Text] [Related]  

  • 11. Efficacy of enalapril in the treatment of erythrocytosis in patients with renal allografts.
    Carvalho MF; Balbi AL; Corrêa LA; Soares VA
    Transplant Proc; 1996 Dec; 28(6):3377. PubMed ID: 8962316
    [No Abstract]   [Full Text] [Related]  

  • 12. [Transferrin and ferritin as laboratory indices of body iron deposits].
    Bobilewicz D; Jabłońska E; Iwanowska M; Zborowska H; Jasińska A
    Pol Tyg Lek; 1995 Oct; 50(40-44):42-4. PubMed ID: 8650058
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Concentration of ferritin, transferrin and iron as a markers of iron deficiency in healthy women in reproductive age].
    Chełchowska M; Laskowska-Klita T; Leibschang J
    Pol Merkur Lekarski; 2007 Jan; 22(127):25-7. PubMed ID: 17477085
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Erythrocytosis after renal transplantation. A prospective analysis.
    Sumrani NB; Daskalakis P; Miles AM; Sarkar S; Markell MS; Hong JH; Friedman EA; Sommer BG
    ASAIO J; 1993; 39(1):51-5. PubMed ID: 8439681
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transferrin receptor assay and zinc protoporphyrin as markers of iron-deficient erythropoiesis in end-stage renal disease patients.
    Baldus M; Walter H; Thies K; Anders C; Stein M; Hellstern P; Brass H
    Clin Nephrol; 1998 Mar; 49(3):186-92. PubMed ID: 9543601
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Monitoring iron status in end-stage renal disease patients on hemodialysis.
    Rafi A; Karkar A; Abdelrahman M
    Saudi J Kidney Dis Transpl; 2007 Mar; 18(1):73-8. PubMed ID: 17237895
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Influence of inflammation on the relation between markers of iron deficiency in renal replacement therapy.
    Yavuz A; Akbaş SH; Tuncer M; Kolağasi O; Cetinkaya R; Gürkan A; Demirbaş A; Gultekin M; Akaydin M; Ersoy F; Yakupoğlu G
    Transplant Proc; 2004; 36(1):41-3. PubMed ID: 15013295
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Usefulness and safety of treatment with captopril in posttransplant erythrocytosis.
    Hernández E; Morales JM; Andrés A; Ortuño B; Praga M; Alcazar JM; Fernández G; Rodicio JL
    Transplant Proc; 1995 Aug; 27(4):2239-41. PubMed ID: 7652789
    [No Abstract]   [Full Text] [Related]  

  • 19. Postrenal transplant erythrocytosis: risk factors and effectiveness of angiotensin receptor antagonists.
    Singh V; Sud K; Mittal BR; Kohli HS; Gupta KL; Sakhuja V
    Transplant Proc; 2002 Dec; 34(8):3191-2. PubMed ID: 12493416
    [No Abstract]   [Full Text] [Related]  

  • 20. Erythrocytosis in renal graft recipients due to a direct effect of cyclosporine.
    Stockenhuber F; Geissler K; Sunder-Plassmann G; Kurz RW; Steininger R; Muehlbacher F; Hinterberger W; Balcke P
    Transplant Proc; 1989 Feb; 21(1 Pt 2):1560-2. PubMed ID: 2652507
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.